March 2012

Click to download the PDF to view the full issue

March 1, 2012/by Administrator

Share this entry

https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 Administrator https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Administrator2012-03-01 12:12:312015-03-15 12:16:05March 2012

Recent

CEPI-Backed Novavax Doses First Patients with COVID-19 Vaccine...May 27, 2020 - 2:52 am
FDA Approves Dupixent for Children with Moderate-to-Severe...May 26, 2020 - 11:39 am
Argenx’s Myasthenia Gravis Drug Shows Positive Results...May 26, 2020 - 11:10 am
WHO Pauses Hydroxychloroquine Arm of COVID-19 StudyMay 26, 2020 - 10:38 am

Popular

CEPI-Backed Novavax Doses First Patients with COVID-19 Vaccine...May 27, 2020 - 2:52 am
M&A, Partnerships And CollaborationsJanuary 1, 2011 - 1:48 pm
OTC Review And OutlookMarch 9, 2011 - 4:17 pm
Global Contract Manufacturing Companies: Pharmaceutical...November 11, 2011 - 3:31 pm

Tags

Abbott appointments biotech cancer Central Nervous System clinical trials Congress contract sales forces CRM depression Drugs in Development earnings featured first quarter gene sequencing genomes HCB Health healthcare advertising agencies Infectious Disease Intouch Solutions KOLs legislation Medidata mHealth mobile multichannel marketing Neurodegenerative Diseases Oncology Pain and Inflammation pharmaceutical marketing pharmaceutical promotion pharmceutical promotion PhRMA Publicis Quintiles rare disease recruitment Shire social media stroke Synthetic Biologics talent Validic Veeva Wearables

Fenruary 2012 April 2012

Scroll to top